In addition, the complimentary removal of murine MHC class II molecules, the main target of human CD4+ T lymphocyte-mediated GvHD responses, further improved the generation of human antigen-specific immune responses in immunodeficient mice reconstituted with human cells while reducing the risk of xenogeneic GvHD development (119). Here, CD4 is linked to graft versus host disease.